Australia and New Zealand Remote Healthcare Market to Grow at a CAGR of 27.3% to reach US$ 8,317.66 million from 2022 to 2028

report image

Australia and New Zealand Remote Healthcare Market Forecast to 2028 - COVID-19 Impact and Country Analysis By Service (Real Time Virtual Health, Remote Patient Monitoring, and Tele-ICUs); and End-User (Healthcare Providers, Patients, Payers, Employer Groups and Government Organizations)

Publication Month: Dec 2022 | Report Code: TIPRE00029787 | No. of Pages: 132 | Category: Healthcare IT | Status: Published

The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021 and is expected to reach US$ 8,317.66 million by 2028; it is anticipated to record a CAGR of 27.3% from 2022 to 2028.

Remote health is revolutionizing the healthcare industry and can be seen as a subset of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time. Moreover, it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.

The growth of the Australia and New Zealand remote healthcare market is attributed to the factors such as rise in the use of telehealth and virtual care during the COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns are hampering the market growth.

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)

New Zealand Remote Healthcare Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

Market Insights

Increase in Number of Digital Health Users

People in Australia and New Zealand are already using digital apps, tools, and services as the preferred way to manage their personal and professional lives. Telehealth remains a constant part of Australia’s health system, which has enhanced access to quality health care for Australians. More than 100 million telehealth services have been provided to 17 million Australians since March 2020. Digital health is an umbrella term indicating a range of technologies that can be used to treat patients and gather and share a person’s health information. Digital health includes mobile health, electronic prescribing, electronic health records, telemedicine and telehealth, and robotics and artificial intelligence.

According to the Australian Digital Health Agency (ADHA) statistics, the number of records with data in them on My Health Record grew from 5.39 million in January 2019 to 22.31 million in December 2021, with more than 537 million documents uploaded. Monthly views of content on the platform were 476% higher between July and December 2021 (6.08 million avg/month) compared with pre-pandemic views from March 2019 to February 2020 (1.06 million avg/month).

Now and in the future, high-quality digital information remains an important aspect of health care. In particular, improving standardizing and health data development could lead to better information to use and share within the health care system. Thus, the improving user experience in digital health is expected to catalyze the growth of the Australia and New Zealand remote healthcare market.

The COVID-19 outbreak positively impacted the growth of the remote healthcare market in Asia Pacific. The Government of Australia expanded Australians' access to telehealth in March 2020 to minimize the risk of community transmission. Over 200 telehealth services were made permanently available. The MBS video and telephone services are available nationally from medical specialists, GPs, and other health professionals. In July 2022, a new temporary telehealth service was introduced that allows longer telephone consultations for patients who have received a positive COVID-19 test. Also, virtual health care (VHC) COVID-19 home monitoring for patients with mild to moderate illness was adopted as a central strategy in Australia to reduce pressure away from acute health systems. Thus, the growing government support for remote patient monitoring for the treatment of COVID-19 is supporting the Australia and New Zealand remote healthcare market.

Service-Based Insights

Based on service, the remote healthcare market is segmented into real time virtual health, remote patient monitoring, and tele-ICUs. The remote patient monitoring segment held the largest market share in 2021. However, the real time virtual health segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028). Remote patient monitoring (RPM) is a method of healthcare delivery through digital health platforms that enables patients to be evaluated outside traditional healthcare settings, in their homes, or community. RPM can significantly reduce a patient's time in the hospital and allow them to recover under monitoring at home. RPM is especially effective for chronic conditions such as heart disease, chronic obstructive pulmonary disease (COPD), and asthma. Also, a rise in product development is likely to favor the market growth. During the pandemic, “COVIDWatch” was developed by the University of Pennsylvania's health system. It is an RPM program that uses automated twice-daily short message service questionnaires to track symptoms.

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028

Australia and New Zealand Remote Healthcare Market, by Service – 2021 and 2028

Get more information on this report :

End User-Based Insights

Based on end user, the remote healthcare market is segmented into healthcare providers, patients, payers, and employer groups & government organizations. The healthcare providers segment held the largest share of the market in 2021. However, the payers segment is anticipated to register the highest CAGR in the market during the forecast period (2022–2028).

Strategic Insights

Report Coverage - Australia and New Zealand Remote Healthcare Market
Report CoverageDetails
Market Size Value inUS$ 1,545.82 Million in 2021
Market Size Value byUS$ 8,317.66 Million by 2028
Growth rateCAGR of 27.3% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages132
No. of Tables9
No. of Charts & Figures24
Historical data availableYes
Segments coveredService, and End-User
Regional scopeAsia Pacific
Country scopeAustralia and New Zealand
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Various companies in the Australia and New Zealand remote healthcare market focus on the collaboration strategy to expand their clientele, which, in turn, helps them maintain their brand name across the world.

The Australia and New Zealand remote healthcare market is segmented based on service and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and tele-ICU. In terms of end user, the market is segmented into healthcare providers, patients, payers, and employer groups and government organizations.

Company Profiles

  • BIOTRONIK SE & Co KG
  • Koninklijke Philips NV
  • Hicuity Health Inc
  • Medtronic Plc
  • American Well Corp
  • Teladoc Health Inc
  • BioTelemetry Inc
  • Abbott Laboratories
  • GE HealthCare
  • Siemens Healthcare GmbH

Frequently Asked Questions

Remote health is revolutionizing the healthcare industry and can be seen as a sub-set of healthcare IT that offers medical assistance to remotely located patients. It is a telemedicine service that minimizes hospital visits and reduces patient waiting time, along with which it allows constant monitoring of the patient's condition and performs preventive and control check-ups outside medical facilities. This form of care is done using mobile devices which measure vital signs.
The factors that are driving the growth of market are rise in use of telehealth and virtual care during COVID-19 pandemic and increase in investment in telehealth. However, data safeguarding concerns is the major factor hindering the remote healthcare market growth.
The remote healthcare market majorly consists of the players, such as BIOTRONIK SE & Co KG, Koninklijke Philips NV, Hicuity Health Inc, Medtronic Plc, American Well Corp, Teladoc Health Inc, BioTelemetry Inc, Abbott Laboratories, GE HealthCare, and Siemens Healthcare GmbH among others.
The market is estimated to grow at a CAGR of 27.3% during the forecast period.
The Australia and New Zealand remote healthcare market was valued at US$ 1,545.82 million in 2021.
The Australia and New Zealand remote healthcare market is expected to reach US$ 8,317.66 million by 2028.
The Australia and New Zealand remote healthcare market is analyzed based on service type and end user. Based on service, the market is segmented into real time virtual health, remote patient monitoring, and Tele-ICUs. In 2021, the remote patient monitoring segment held the largest share of the market. However, the real time virtual health segment is anticipated to register the highest CAGR during the forecast period.
Australia accounts for the major market share of remote healthcare market in 2021 due to increasing aging population and rising prevalence of chronic illnesses.

The List of Companies - Australia and New Zealand Remote Healthcare Market

  1. BIOTRONIK SE & Co KG
  2. Koninklijke Philips NV
  3. Hicuity Health Inc
  4. Medtronic Plc
  5. American Well Corp
  6. Teladoc Health Inc
  7. BioTelemetry Inc
  8. Abbott Laboratories
  9. GE HealthCare
  10. Siemens Healthcare GmbH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Australia and New Zealand remote healthcare market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Australia and New Zealand remote healthcare market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth country market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00029787
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $2000 $1800
  • $3000 $2400
  • $4000 $3200
  • $5000 $4000

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount